{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:41:56Z","timestamp":1790804516282,"version":"4.1.0"},"reference-count":105,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,11]],"date-time":"2024-08-11T00:00:00Z","timestamp":1723334400000},"content-version":"am","delay-in-days":376,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.revmed.2023.05.003","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T14:45:45Z","timestamp":1685630745000},"page":"410-422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Atteinte digestive de la scl\u00e9rodermie syst\u00e9mique"],"prefix":"10.1016","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8029-9417","authenticated-orcid":false,"given":"A.","family":"Renaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Jirka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Durant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Connault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Espitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Takoudju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Agard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2023.05.003_bib0535","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat Rev Dis Primer"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0540","doi-asserted-by":"crossref","first-page":"104087","DOI":"10.1016\/j.lpm.2021.104087","article-title":"Pathophysiology of systemic sclerosis","volume":"50","author":"Thoreau","year":"2021","journal-title":"Press Med"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0545","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.revmed.2023.05.003_bib0550","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1002\/art.41153","article-title":"Using autoantibodies and cutaneous subset to develop outcome-based disease classification in systemic sclerosis","volume":"72","author":"Nihtyanova","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2023.05.003_bib0555","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1136\/ard.2009.114264","article-title":"Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database","volume":"69","author":"Tyndall","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib0560","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1136\/annrheumdis-2016-209909","article-title":"Update of EULAR recommendations for the treatment of systemic sclerosis","volume":"76","author":"Kowal-Bielecka","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"Suppl. 2","key":"10.1016\/j.revmed.2023.05.003_bib0565","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1186\/s13023-021-01844-y","article-title":"French recommendations for the management of systemic sclerosis","volume":"16","author":"Hachulla","year":"2021","journal-title":"Orphanet J Rare Dis"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib0570","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nrgastro.2016.99","article-title":"Current management of the gastrointestinal complications of systemic sclerosis","volume":"13","author":"Emmanuel","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0575","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1093\/rheumatology\/keq147","article-title":"Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre","volume":"49","author":"Thoua","year":"2010","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0580","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1002\/acr.23479","article-title":"Determining the risk factors and clinical features associated with severe gastrointestinal dysmotility in systemic sclerosis","volume":"70","author":"McMahan","year":"2018","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0585","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1093\/rheumatology\/key350","article-title":"Severe gastrointestinal disease in very early systemic sclerosis is associated with early mortality","volume":"58","author":"Richard","year":"2019","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib0590","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1093\/rheumatology\/ken179","article-title":"The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement","volume":"47","author":"Hunzelmann","year":"2008","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0595","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0016-5085(87)90137-5","article-title":"Esophagitis in scleroderma. Prevalence and risk factors","volume":"92","author":"Zamost","year":"1987","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0600","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/0002-9343(87)90376-7","article-title":"Barrett's metaplasia and adenocarcinoma of the esophagus in scleroderma","volume":"82","author":"Katzka","year":"1987","journal-title":"Am J Med"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0605","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0049-0172(94)90097-3","article-title":"Gastrointestinal manifestations of systemic sclerosis","volume":"24","author":"Abu-Shakra","year":"1994","journal-title":"Semin Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0610","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/art.21261","article-title":"Prevalence of Barrett's esophagus in systemic sclerosis","volume":"52","author":"Wipff","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib0615","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/rheumatology\/ker110","article-title":"Outcomes of Barrett's oesophagus related to systemic sclerosis: a 3-year EULAR Scleroderma Trials and Research prospective follow-up study","volume":"50","author":"Wipff","year":"2011","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0620","first-page":"115","article-title":"High-resolution oesophageal manometry and 24-hour impedance-pH study in systemic sclerosis patients: association with clinical features, symptoms and severity","volume":"34 Suppl. 100","author":"Raja","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0625","first-page":"63","article-title":"Esophageal and anorectal involvement in systemic sclerosis: a systematic assessment with high resolution manometry","volume":"34 Suppl. 100","author":"Luciano","year":"2016","journal-title":"Clin Exp Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.cgh.2016.08.034","article-title":"Esophageal motor abnormalities in patients with scleroderma: heterogeneity, risk factors, and effects on quality of life","volume":"15","author":"Crowell","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0635","first-page":"82","article-title":"Severe oesophageal disease and its associations with systemic sclerosis","volume":"35 Suppl. 106","author":"Karamanolis","year":"2017","journal-title":"Clin Exp Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0640","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1365-2036.1992.tb00571.x","article-title":"Omeprazole in the long-term treatment of severe gastro-oesophageal reflux disease in patients with systemic sclerosis","volume":"6","author":"Hendel","year":"1992","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0645","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-2036.1993.tb00126.x","article-title":"The extent and pattern of gastro-oesophageal reflux in patients with scleroderma oesophagus: the effect of low-dose omeprazole","volume":"7","author":"Shoenut","year":"1993","journal-title":"Aliment Pharmacol Ther"},{"issue":"3 Suppl. 54","key":"10.1016\/j.revmed.2023.05.003_bib0650","first-page":"15","article-title":"Scoring of reflux symptoms associated with scleroderma and the usefulness of rabeprazole","volume":"27","author":"Muro","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"3 Suppl. 54","key":"10.1016\/j.revmed.2023.05.003_bib0655","first-page":"5","article-title":"Does long-term therapy with lansoprazole slow progression of oesophageal involvement in systemic sclerosis?","volume":"27","author":"Pakozdi","year":"2009","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0660","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/s41598-020-57636-0","article-title":"Prevalence and predictors of proton pump inhibitor partial response in gastroesophageal reflux disease in systemic sclerosis: a prospective study","volume":"10","author":"Foocharoen","year":"2020","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0665","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/art.1780200105","article-title":"Stimulatory effect of metoclopramide on the esophagus and lower esophageal sphincter of patients of patients with PSS","volume":"20","author":"Ramirez-Mata","year":"1977","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0670","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/archinte.1987.00370090075014","article-title":"Metoclopramide response in patients with progressive systemic sclerosis. Effect on esophageal and gastric motility abnormalities","volume":"147","author":"Johnson","year":"1987","journal-title":"Arch Intern Med"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0675","first-page":"810","article-title":"Scintigraphic detection of metoclopramide esophageal stimulation in progressive systemic sclerosis","volume":"28","author":"Drane","year":"1987","journal-title":"J Nucl Med"},{"key":"10.1016\/j.revmed.2023.05.003_bib0680","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s13075-016-1094-y","article-title":"The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial","volume":"18","author":"Karamanolis","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0685","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/rheumatology\/kew216","article-title":"Effectiveness of add-on therapy with domperidone vs alginic acid in proton pump inhibitor partial response gastro-oesophageal reflux disease in systemic sclerosis: randomized placebo-controlled trial","volume":"56","author":"Foocharoen","year":"2017","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0690","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.mcna.2018.08.002","article-title":"Proton pump inhibitor\u2013refractory gastroesophageal reflux disease","volume":"103","author":"Yadlapati","year":"2019","journal-title":"Med Clin North Am"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0700","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s00423-021-02118-8","article-title":"Surgical treatment of recalcitrant gastroesophageal reflux disease in patients with systemic sclerosis: a systematic review","volume":"406","author":"Aiolfi","year":"2021","journal-title":"Langenbecks Arch Surg"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0705","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.mayocp.2017.10.022","article-title":"Proton pump inhibitors: review of emerging concerns","volume":"93","author":"Nehra","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.revmed.2023.05.003_bib0710","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0022-2143(98)90133-0","article-title":"Prevalence of impaired gastric emptying of solids in systemic sclerosis: diagnostic and therapeutic implications","volume":"132","author":"Sridhar","year":"1998","journal-title":"J Lab Clin Med"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0715","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1572-0241.2001.03353.x","article-title":"Gastric involvement in systemic sclerosis: a prospective study","volume":"96","author":"Marie","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.revmed.2023.05.003_bib0720","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/rheumatology\/kes429","article-title":"Gastrointestinal motility disorder assessment in systemic sclerosis","volume":"52","author":"Savarino","year":"2013","journal-title":"Rheumatology"},{"issue":"6","key":"10.1016\/j.revmed.2023.05.003_bib0725","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/03009740410005016","article-title":"Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity","volume":"32","author":"Franck-Larsson","year":"2003","journal-title":"Scand J Rheumatol"},{"issue":"7","key":"10.1016\/j.revmed.2023.05.003_bib0730","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1002\/art.34374","article-title":"Delayed gastric emptying determined using the 13C-octanoic acid breath test in patients with systemic sclerosis","volume":"64","author":"Marie","year":"2012","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0735","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1007\/s00296-010-1779-5","article-title":"Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study","volume":"32","author":"Cozzi","year":"2012","journal-title":"Rheumatol Int"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0740","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3109\/00365529409092515","article-title":"Effect of erythromycin administration on upper gastrointestinal motility in scleroderma patients","volume":"29","author":"Fiorucci","year":"1994","journal-title":"Scand J Gastroenterol"},{"issue":"2 Suppl. 76","key":"10.1016\/j.revmed.2023.05.003_bib0745","first-page":"140","article-title":"Prolonged treatment with transcutaneous electrical nerve stimulation (TENS) modulates neuro-gastric motility and plasma levels of vasoactive intestinal peptide (VIP), motilin and interleukin-6 (IL-6) in systemic sclerosis","volume":"31","author":"McNearney","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0750","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1111\/j.1365-2036.2008.03739.x","article-title":"Watermelon stomach in systemic sclerosis: its incidence and management","volume":"28","author":"Marie","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"10.1016\/j.revmed.2023.05.003_bib0755","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3899\/jrheum.090600","article-title":"Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictors","volume":"37","author":"Ingraham","year":"2010","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0760","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3899\/jrheum.121087","article-title":"Gastric antral vascular ectasia and its clinical correlates in patients with early diffuse systemic sclerosis in the SCOT trial","volume":"40","author":"Hung","year":"2013","journal-title":"J Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0765","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3899\/jrheum.130386","article-title":"Prevalence, correlates and outcomes of gastric antral vascular ectasia in systemic sclerosis: a EUSTAR case-control study","volume":"41","author":"Ghr\u00e9nassia","year":"2014","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0770","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.semarthrit.2020.06.016","article-title":"Gastric antral vascular ectasia in systemic sclerosis: association with anti-RNA polymerase III and negative anti-nuclear antibodies","volume":"50","author":"Serling-Boyd","year":"2020","journal-title":"Semin Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.revmed.2023.05.003_bib0775","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.annder.2017.10.016","article-title":"[Late-onset systemic sclerosis: a retrospective study of 27 patients diagnosed after the age of 70]","volume":"145","author":"Achille","year":"2018","journal-title":"Ann Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0780","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1572-0241.2006.00370.x","article-title":"Argon plasma coagulation in the management of symptomatic gastrointestinal vascular lesions: experience in 100 consecutive patients with long-term follow-up","volume":"101","author":"Kwan","year":"2006","journal-title":"Am J Gastroenterol"},{"issue":"06","key":"10.1016\/j.revmed.2023.05.003_bib0785","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0034-1391395","article-title":"Gastric antral vascular ectasia: a prospective study of treatment with endoscopic band ligation","volume":"47","author":"Zepeda-G\u00f3mez","year":"2015","journal-title":"Endoscopy"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0790","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/1751-2980.12958","article-title":"Endoscopic treatment of gastric antral vascular ectasia in real-life settings: Argon plasma coagulation or endoscopic band ligation?","volume":"22","author":"F\u00e1bi\u00e1n","year":"2021","journal-title":"J Dig Dis"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib0795","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1007\/s10067-020-05549-8","article-title":"Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis","volume":"40","author":"Feng","year":"2021","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0800","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.gtc.2017.09.008","article-title":"Small intestinal bacterial overgrowth: nutritional implications, diagnosis, and management","volume":"47","author":"Adike","year":"2018","journal-title":"Gastroenterol Clin North Am"},{"issue":"4 Suppl. 91","key":"10.1016\/j.revmed.2023.05.003_bib0805","first-page":"S117","article-title":"What tests should you use to assess small intestinal bacterial overgrowth in systemic sclerosis?","volume":"33","author":"Braun-Moscovici","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"10.1016\/j.revmed.2023.05.003_bib0810","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/rheumatology\/key175","article-title":"Treatment of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review","volume":"57","author":"Pittman","year":"2018","journal-title":"Rheumatology"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0815","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.semarthrit.2018.12.001","article-title":"The efficacy of dietary intervention on gastrointestinal involvement in systemic sclerosis: a systematic literature review","volume":"49","author":"Smith","year":"2019","journal-title":"Semin Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.revmed.2023.05.003_bib0820","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.3899\/jrheum.131547","article-title":"Mortality, recurrence, and hospital course of patients with systemic sclerosis-related acute intestinal pseudo-obstruction","volume":"41","author":"Mecoli","year":"2014","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0825","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1093\/rheumatology\/kev393","article-title":"Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample","volume":"55","author":"Valenzuela","year":"2016","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib0830","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1007\/s00330-008-0913-1","article-title":"Chronic intestinal pseudo-obstruction in adult patients: multidetector row helical CT features","volume":"18","author":"Merlin","year":"2008","journal-title":"Eur Radiol"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0835","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1007\/BF02208652","article-title":"Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction","volume":"40","author":"Verne","year":"1995","journal-title":"Dig Dis Sci"},{"issue":"3","key":"10.1016\/j.revmed.2023.05.003_bib0840","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/RHU.0b013e3180645d2a","article-title":"Treatment of small intestinal disease in systemic sclerosis with octreotide: a prospective study in seven patients","volume":"13","author":"Nikou","year":"2007","journal-title":"J Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0845","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13075-017-1340-y","article-title":"Preliminary safety and efficacy profile of prucalopride in the treatment of systemic sclerosis (SSc)-related intestinal involvement: results from the open label cross-over PROGASS study","volume":"19","author":"Vigone","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.revmed.2023.05.003_bib0850","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1111\/nmo.12735","article-title":"Comparative quantitative assessment of global small bowel motility using magnetic resonance imaging in chronic intestinal pseudo-obstruction and healthy controls","volume":"28","author":"Menys","year":"2016","journal-title":"Neurogastroenterol Motil"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0855","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.semarthrit.2017.12.007","article-title":"Pyridostigmine for the treatment of gastrointestinal symptoms in systemic sclerosis","volume":"48","author":"Ahuja","year":"2018","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0860","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/apt.12818","article-title":"Gastrointestinal mucosal abnormalities using videocapsule endoscopy in systemic sclerosis","volume":"40","author":"Marie","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0865","doi-asserted-by":"crossref","first-page":"615","DOI":"10.2169\/internalmedicine.8034-21","article-title":"Characteristics and treatment outcomes of small-bowel angioectasia in systemic sclerosis patients: a retrospective observational study","volume":"61","author":"Iio","year":"2022","journal-title":"Intern Med"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0870","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/apt.12527","article-title":"Review article: gastrointestinal angiodysplasia\u00a0\u2013\u00a0pathogenesis, diagnosis and management","volume":"39","author":"Sami","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0875","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2011.07.018","article-title":"Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation","volume":"141","author":"Ge","year":"2011","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib0880","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1007\/s10620-010-1193-6","article-title":"Somatostatin analogues in the treatment of recurrent bleeding from gastrointestinal vascular malformations: an overview and systematic review of prospective observational studies","volume":"55","author":"Brown","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"7","key":"10.1016\/j.revmed.2023.05.003_bib0885","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1177\/2050640616688129","article-title":"Prevalence of fecal incontinence in a cohort of systemic sclerosis patients within a regional referral network","volume":"5","author":"Garros","year":"2017","journal-title":"United Eur Gastroenterol J"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0890","first-page":"581","article-title":"Clinical correlates of faecal incontinence in systemic sclerosis: identifying therapeutic avenues","volume":"56","author":"Richard","year":"2017","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0895","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/BF02051176","article-title":"Anorectal dysfunction and rectal prolapse in progressive systemic sclerosis","volume":"36","author":"Leighton","year":"1993","journal-title":"Dis Colon Rectum"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0900","doi-asserted-by":"crossref","first-page":"100","DOI":"10.5114\/reum.2017.67606","article-title":"Stubborn rectal prolapse in systemic sclerosis","volume":"55","author":"Petersen","year":"2017","journal-title":"Reumatologia"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0905","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/ajg.2011.399","article-title":"Fecal incontinence in systemic sclerosis is secondary to neuropathy","volume":"107","author":"Thoua","year":"2012","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0910","doi-asserted-by":"crossref","first-page":"391","DOI":"10.3109\/03009742.2014.889210","article-title":"Vascular events are risk factors for anal incontinence in systemic sclerosis: a study of morphology and functional properties measured by anal endosonography and manometry","volume":"43","author":"Bartosik","year":"2014","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0915","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.3109\/00365521.2014.913188","article-title":"Physiological and structural anorectal abnormalities in patients with systemic sclerosis and fecal incontinence","volume":"49","author":"Franck-Larsson","year":"2014","journal-title":"Scand J Gastroenterol"},{"issue":"9","key":"10.1016\/j.revmed.2023.05.003_bib0920","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/rheumatology\/ker153","article-title":"Internal anal sphincter atrophy in patients with systemic sclerosis","volume":"50","author":"Thoua","year":"2011","journal-title":"Rheumatology"},{"issue":"12","key":"10.1016\/j.revmed.2023.05.003_bib0925","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1080\/00365521.2016.1218537","article-title":"Efficacy of anorectal biofeedback in scleroderma patients with fecal incontinence: a case-control study","volume":"51","author":"Collins","year":"2016","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"10.1016\/j.revmed.2023.05.003_bib0930","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1136\/gut.51.6.881","article-title":"Sacral nerve stimulation for faecal incontinence due to systemic sclerosis","volume":"51","author":"Kenefick","year":"2002","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.revmed.2023.05.003_bib0935","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/codi.12969","article-title":"Lack of effect of sacral nerve stimulation for incontinence in patients with systemic sclerosis","volume":"17","author":"Butt","year":"2015","journal-title":"Colorectal Dis"},{"key":"10.1016\/j.revmed.2023.05.003_bib0940","article-title":"High failure rate following restorative surgery for rectal prolapse in systemic sclerosis patients","author":"Kahana","year":"2021","journal-title":"Am Surg"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0945","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s40258-018-0447-x","article-title":"Peristeen transanal irrigation system to manage bowel dysfunction: a NICE medical technology guidance","volume":"17","author":"Dale","year":"2019","journal-title":"Appl Health Econ Health Policy"},{"issue":"12","key":"10.1016\/j.revmed.2023.05.003_bib0950","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.3899\/jrheum.090694","article-title":"Malnutrition is common in systemic sclerosis: results from the Canadian scleroderma research group database","volume":"36","author":"Baron","year":"2009","journal-title":"J Rheumatol"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0955","first-page":"666","article-title":"Disease-related malnutrition in outpatients with systemic sclerosis","volume":"31","author":"Caporali","year":"2012","journal-title":"Clin Nutr Edinb Scotl"},{"issue":"11","key":"10.1016\/j.revmed.2023.05.003_bib0960","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.autrev.2018.05.010","article-title":"Impact of micronutrient deficiency & malnutrition in systemic sclerosis: cohort study and literature review","volume":"17","author":"Dupont","year":"2018","journal-title":"Autoimmun Rev"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib0965","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s10067-019-04810-z","article-title":"Prevalence of malnutrition in systemic sclerosis patients assessed by different diagnostic tools","volume":"39","author":"Wojteczek","year":"2020","journal-title":"Clin Rheumatol"},{"issue":"11","key":"10.1016\/j.revmed.2023.05.003_bib0970","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1136\/ard.2009.123273","article-title":"Nutritional status as marker for disease activity and severity predicting mortality in patients with systemic sclerosis","volume":"69","author":"Krause","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib0975","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/s41430-018-0116-z","article-title":"The impact of malnutrition on quality of life in patients with systemic sclerosis","volume":"72","author":"Preis","year":"2018","journal-title":"Eur J Clin Nutr"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0980","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1016\/j.lpm.2010.09.019","article-title":"Mood and anxiety disorders in systemic sclerosis patients","volume":"40","author":"Baubet","year":"2011","journal-title":"Press Med"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib0985","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.revmed.2020.08.014","article-title":"\u00c9tude monocentrique sur les m\u00e9dicaments pris par les patients pour le traitement de la scl\u00e9rodermie syst\u00e9mique","volume":"42","author":"Renaud","year":"2021","journal-title":"Rev Med Interne"},{"issue":"2 Suppl. 58","key":"10.1016\/j.revmed.2023.05.003_bib0990","first-page":"S42","article-title":"Screening and therapy for malnutrition and related gastro-intestinal disorders in systemic sclerosis: recommendations of a North American expert panel","volume":"28","author":"Baron","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.revmed.2023.05.003_bib0995","series-title":"Diagnostic de la d\u00e9nutrition chez l\u2019enfant, l\u2019adulte, et la personne de 70\u00a0ans et plus","author":"Haute Autorit\u00e9 de sant\u00e9","year":"2021"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib1000","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/0148607115597883","article-title":"Medical nutrition therapy for patients with advanced systemic sclerosis (MNT PASS): a pilot intervention study","volume":"41","author":"Doerfler","year":"2017","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"3","key":"10.1016\/j.revmed.2023.05.003_bib1005","doi-asserted-by":"crossref","first-page":"266","DOI":"10.3109\/03009740903468990","article-title":"Percutaneous endoscopic gastrostomy in patients with systemic sclerosis","volume":"39","author":"Fynne","year":"2010","journal-title":"Scand J Rheumatol"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib1010","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/rheumatology\/kem329","article-title":"Home parenteral nutrition\u00a0\u2013\u00a0an effective and safe long-term therapy for systemic sclerosis-related intestinal failure","volume":"47","author":"Brown","year":"2008","journal-title":"Rheumatology"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib1015","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.3899\/jrheum.110896","article-title":"Home parenteral nutrition in patients with systemic sclerosis: a retrospective review of 12 cases","volume":"39","author":"Jawa","year":"2012","journal-title":"J Rheumatol"},{"issue":"8","key":"10.1016\/j.revmed.2023.05.003_bib1020","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3390\/diagnostics10080587","article-title":"The role of fecal calprotectin in patients with systemic sclerosis and small intestinal bacterial overgrowth (SIBO)","volume":"10","author":"Polkowska-Pruszy\u0144ska","year":"2020","journal-title":"Diagnostics"},{"key":"10.1016\/j.revmed.2023.05.003_bib1025","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejrad.2018.06.022","article-title":"18F-FDG PET-MRI with T1 MOLLI mapping to detect systemic sclerosis bowel inflammation and fibrosis","volume":"105","author":"Marchesseau","year":"2018","journal-title":"Eur J Radiol"},{"issue":"2","key":"10.1016\/j.revmed.2023.05.003_bib1030","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3892\/br.2020.1401","article-title":"Use of vonoprazan for management of systemic sclerosis-related gastroesophageal reflux disease","volume":"14","author":"Tabuchi","year":"2021","journal-title":"Biomed Rep"},{"key":"10.1016\/j.revmed.2023.05.003_bib1035","article-title":"Efficacy and safety of robotic Dor Fundoplication on severe gastroesophageal reflux disease in patients with scleroderma","volume":"9","author":"Loganathan","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"issue":"7","key":"10.1016\/j.revmed.2023.05.003_bib1040","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ14-0088","article-title":"Clinical effects of ghrelin on gastrointestinal involvement in patients with systemic sclerosis","volume":"61","author":"Ariyasu","year":"2014","journal-title":"Endocr J"},{"issue":"7","key":"10.1016\/j.revmed.2023.05.003_bib1045","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1080\/00365521.2020.1761997","article-title":"G-POEM may be an optional treatment for refractory gastroparesis in systemic sclerosis","volume":"55","author":"Gonzalez","year":"2020","journal-title":"Scand J Gastroenterol"},{"issue":"4","key":"10.1016\/j.revmed.2023.05.003_bib1050","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1007\/s10620-019-05830-0","article-title":"Effectiveness of Saccharomyces boulardii and metronidazole for small intestinal bacterial overgrowth in systemic sclerosis","volume":"65","author":"Garc\u00eda-Collinot","year":"2020","journal-title":"Dig Dis Sci"},{"issue":"1","key":"10.1016\/j.revmed.2023.05.003_bib1055","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12876-021-01738-0","article-title":"Linaclotide for the treatment of refractory lower bowel manifestations of systemic sclerosis","volume":"21","author":"Dein","year":"2021","journal-title":"BMC Gastroenterol"},{"issue":"5","key":"10.1016\/j.revmed.2023.05.003_bib0525","doi-asserted-by":"crossref","first-page":"e0232739","DOI":"10.1371\/journal.pone.0232739","article-title":"Fecal microbiota transplantation in systemic sclerosis: a double-blind, placebo-controlled randomized pilot trial. Nurmohamed M, \u00e9diteur","volume":"15","author":"Fretheim","year":"2020","journal-title":"PLoS One"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323005891?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866323005891?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:46:34Z","timestamp":1759337194000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866323005891"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":105,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0248866323005891"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2023.05.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atteinte digestive de la scl\u00e9rodermie syst\u00e9mique","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2023.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 Nationale Fran\u00e7aise de M\u00e9decine Interne (SNFMI). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}